Subgroup Analysis by Prior Treatment of the Efficacy and Safety of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma in the PANORAMA 1 Study
| Autor: | Richardson, P.G., Hungria, V.T.M., Yoon, S.-S., Beksac, M., Dimopoulos, M.A., Elghandour, A., Jedrzejczak, W.W., Guenther, A., Nakorn, T.N., Siritanaratkul, N., Schlossman, R.L., Hou, J., Moreau, P., Lonial, S., Lee, J.H., Einsele, H., Sopala, M., Bengoudifa, B.R., Corrado, C., San-Miguel, J.F. |
|---|---|
| Zdroj: | In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e78-e78 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect